AU2631001A - Novel fgf homolog zfgf11 - Google Patents
Novel fgf homolog zfgf11Info
- Publication number
- AU2631001A AU2631001A AU26310/01A AU2631001A AU2631001A AU 2631001 A AU2631001 A AU 2631001A AU 26310/01 A AU26310/01 A AU 26310/01A AU 2631001 A AU2631001 A AU 2631001A AU 2631001 A AU2631001 A AU 2631001A
- Authority
- AU
- Australia
- Prior art keywords
- zfgf11
- fgf homolog
- novel fgf
- novel
- homolog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47788600A | 2000-01-05 | 2000-01-05 | |
US09477886 | 2000-01-05 | ||
PCT/US2001/000324 WO2001049849A1 (en) | 2000-01-05 | 2001-01-05 | Novel fgf homolog zfgf11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2631001A true AU2631001A (en) | 2001-07-16 |
Family
ID=23897738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26310/01A Abandoned AU2631001A (en) | 2000-01-05 | 2001-01-05 | Novel fgf homolog zfgf11 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2631001A (en) |
WO (1) | WO2001049849A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7459540B1 (en) | 1999-09-07 | 2008-12-02 | Amgen Inc. | Fibroblast growth factor-like polypeptides |
US7408047B1 (en) | 1999-09-07 | 2008-08-05 | Amgen Inc. | Fibroblast growth factor-like polypeptides |
US6716626B1 (en) | 1999-11-18 | 2004-04-06 | Chiron Corporation | Human FGF-21 nucleic acids |
US7981863B2 (en) | 2001-09-19 | 2011-07-19 | Neuronova Ab | Treatment of Parkinson's disease with PDGF |
AU2006203260B2 (en) * | 2001-09-19 | 2008-12-04 | Newron Sweden Ab | Treatment of Central Nervous System Disorders by Use of PDGF or VEGF |
WO2004003179A1 (en) * | 2002-06-27 | 2004-01-08 | The University Of Queensland | Differentiation modulating agents and uses therefor |
EA200601121A1 (en) | 2003-12-10 | 2006-10-27 | Эли Лилли Энд Компани | MUTEINS OF FIBROBLAST GROWTH FACTOR 21 |
DK2586456T3 (en) * | 2004-10-29 | 2016-03-21 | Ratiopharm Gmbh | Conversion and glycopegylation of fibroblast growth factor (FGF) |
US8486904B2 (en) | 2007-10-01 | 2013-07-16 | Isis Pharmaceuticals, Inc. | Antisense modulation of fibroblast growth factor receptor 4 expression |
JOP20190083A1 (en) | 2008-06-04 | 2017-06-16 | Amgen Inc | Fgf21 mutant fusion polypeptides and uses thereof |
WO2010042747A2 (en) | 2008-10-10 | 2010-04-15 | Amgen Inc. | Fgf21 mutants and uses thereof |
WO2010129600A2 (en) | 2009-05-05 | 2010-11-11 | Amgen Inc. | Fgf21 mutants and uses thereof |
TWI560197B (en) | 2009-05-05 | 2016-12-01 | Amgen Inc | Fgf21 mutants and uses thereof |
MX2011013903A (en) | 2009-06-17 | 2012-05-08 | Amgen Inc | Chimeric fgf19 polypeptides and uses thereof. |
UA109888C2 (en) | 2009-12-07 | 2015-10-26 | ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES | |
AU2011239689A1 (en) | 2010-04-15 | 2012-11-08 | Amgen Inc. | Human FGF receptor and beta-Klotho binding proteins |
EP2721156B1 (en) | 2011-06-16 | 2016-12-21 | Ionis Pharmaceuticals, Inc. | Antisense modulation of fibroblast growth factor receptor 4 expression |
SG10201806648TA (en) | 2011-07-01 | 2018-09-27 | Ngm Biopharmaceuticals Inc | Compositions, uses and methods for treatment of metabolic disorders and diseases |
US9963494B2 (en) | 2012-11-28 | 2018-05-08 | Ngm Biopharmaceuticals, Inc. | Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject |
US9290557B2 (en) | 2012-11-28 | 2016-03-22 | Ngm Biopharmaceuticals, Inc. | Compositions comprising variants and fusions of FGF19 polypeptides |
CN108888757A (en) | 2012-12-27 | 2018-11-27 | 恩格姆生物制药公司 | Method for adjusting bile acid homeostasis and treating bile acid disorder and disease |
US9273107B2 (en) | 2012-12-27 | 2016-03-01 | Ngm Biopharmaceuticals, Inc. | Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
MX2016004822A (en) | 2013-10-28 | 2016-08-17 | Ngm Biopharmaceuticals Inc | Cancer models and associated methods. |
MX2016009555A (en) | 2014-01-24 | 2016-12-08 | Ngm Biopharmaceuticals Inc | Binding proteins and methods of use thereof. |
WO2015183890A2 (en) | 2014-05-28 | 2015-12-03 | Ngm Biopharmaceuticals, Inc. | Methods and compositions for the treatment of metabolic disorders and diseases |
AU2015277438B2 (en) | 2014-06-16 | 2020-02-27 | Ngm Biopharmaceuticals, Inc. | Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
UA123763C2 (en) | 2014-10-23 | 2021-06-02 | Енджіем Байофармасьютикалз, Інк. | Pharmaceutical compositions comprising peptide variants and methods of use thereof |
US10434144B2 (en) | 2014-11-07 | 2019-10-08 | Ngm Biopharmaceuticals, Inc. | Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders |
WO2017019957A2 (en) | 2015-07-29 | 2017-02-02 | Ngm Biopharmaceuticals, Inc. | Binding proteins and methods of use thereof |
AU2016353988B2 (en) | 2015-11-09 | 2019-09-26 | Ngm Biopharmaceuticals, Inc. | Methods for treatment of bile acid-related disorders |
US11370841B2 (en) | 2016-08-26 | 2022-06-28 | Ngm Biopharmaceuticals, Inc. | Methods of treating fibroblast growth factor 19-mediated cancers and tumors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989000198A1 (en) * | 1987-07-07 | 1989-01-12 | Biotechnology Research Associates, J.V. | Recombinant fibroblast growth factors |
US5859208A (en) * | 1988-07-06 | 1999-01-12 | Fiddes; John C. | Human basic fibroblast growth factor analog |
CA2218329A1 (en) * | 1995-06-05 | 1996-12-12 | Human Genome Sciences, Inc. | Fibroblast growth factor-11 |
KR20050009764A (en) * | 1997-11-25 | 2005-01-25 | 제넨테크, 인크. | Fibroblast growth factor-19 |
-
2001
- 2001-01-05 AU AU26310/01A patent/AU2631001A/en not_active Abandoned
- 2001-01-05 WO PCT/US2001/000324 patent/WO2001049849A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001049849A1 (en) | 2001-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2631001A (en) | Novel fgf homolog zfgf11 | |
AU2759201A (en) | Novel fgf homolog zfgf12 | |
AU2001262847A1 (en) | Language-understanding | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
AU2001265871A1 (en) | Substituted sulfonylaminopyrimidines | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001254731A1 (en) | Substituted phenyluracils | |
AU2001258255A1 (en) | Substituted benzoylcyclohexenones | |
AU2001240791A1 (en) | Sequence | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001246864A1 (en) | Hypotensors | |
EP1201403A3 (en) | Electrofusible units | |
AU2001226668A1 (en) | Crankshaft-starter-generator | |
AU2001260192A1 (en) | Glycinamides | |
AU2001262711A1 (en) | Cytoprotectors | |
AU2002219846A1 (en) | Novel use | |
AU2002223604A1 (en) | Substituted phenyluracils | |
AU2001275014A1 (en) | Imidazoloisoquinolines | |
AU2463401A (en) | Novel fgf homolog zfgf10 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |